 | • レポートコード：GIR-105X00702 • 出版社/出版日：GlobalInfoResearch / 2021年5月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、77ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アリムタのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アリムタの種類別市場規模（100mg、500mg）、用途別市場規模（胸膜中皮腫、非小細胞肺癌）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アリムタの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Abbott Healthcare、Cadila Healthcare、Eagle Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100mg、500mg ・用途別分析2016年-2026年：胸膜中皮腫、非小細胞肺癌 ・アリムタの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アリムタのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アリムタのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アリムタの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アリムタの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alimta market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alimta size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Alimta market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alimta market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg
500mg
Market segment by Application can be divided into
Pleural Mesothelioma
Non-small Cell Lung Cancer
The key market players for global Alimta market are listed below:
Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Alimta product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alimta, with price, sales, revenue and global market share of Alimta from 2019 to 2021.
Chapter 3, the Alimta competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alimta breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Alimta market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Alimta sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Alimta Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alimta Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg
1.2.3 500mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Alimta Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pleural Mesothelioma
1.3.3 Non-small Cell Lung Cancer
1.4 Global Alimta Market Size & Forecast
1.4.1 Global Alimta Sales in Value (2016-2026))
1.4.2 Global Alimta Sales in Volume (2016-2026)
1.4.3 Global Alimta Price by Type (2016-2026) & (USD/g)
1.5 Global Alimta Production Capacity Analysis
1.5.1 Global Alimta Total Production Capacity (2016-2026)
1.5.2 Global Alimta Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Alimta Market Drivers
1.6.2 Alimta Market Restraints
1.6.3 Alimta Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Alimta Product and Services
2.1.4 Eli Lilly Alimta Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Abbott Healthcare
2.2.1 Abbott Healthcare Details
2.2.2 Abbott Healthcare Major Business
2.2.3 Abbott Healthcare Alimta Product and Services
2.2.4 Abbott Healthcare Alimta Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Cadila Healthcare
2.3.1 Cadila Healthcare Details
2.3.2 Cadila Healthcare Major Business
2.3.3 Cadila Healthcare Alimta Product and Services
2.3.4 Cadila Healthcare Alimta Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eagle Pharmaceuticals
2.4.1 Eagle Pharmaceuticals Details
2.4.2 Eagle Pharmaceuticals Major Business
2.4.3 Eagle Pharmaceuticals Alimta Product and Services
2.4.4 Eagle Pharmaceuticals Alimta Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Alimta Sales by Manufacturer
3.1 Global Alimta Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Alimta Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Alimta
3.4 Market Concentration Rate
3.4.1 Top 3 Alimta Manufacturer Market Share
3.4.2 Top 6 Alimta Manufacturer Market Share
3.5 Global Alimta Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Alimta Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Alimta Market Size by Region
4.1.1 Global Alimta Sales in Volume by Region (2016-2026)
4.1.2 Global Alimta Revenue by Region (2016-2026)
4.2 North America Alimta Revenue (2016-2026)
4.3 Europe Alimta Revenue (2016-2026)
4.4 Asia-Pacific Alimta Revenue (2016-2026)
4.5 South America Alimta Revenue (2016-2026)
4.6 Middle East and Africa Alimta Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Alimta Sales in Volume by Type (2016-2026)
5.2 Global Alimta Revenue by Type (2016-2026)
5.3 Global Alimta Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Alimta Sales in Volume by Application (2016-2026)
6.2 Global Alimta Revenue by Application (2016-2026)
6.3 Global Alimta Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Alimta Sales by Type (2016-2026)
7.2 North America Alimta Sales by Application (2016-2026)
7.3 North America Alimta Market Size by Country
7.3.1 North America Alimta Sales in Volume by Country (2016-2026)
7.3.2 North America Alimta Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Alimta Sales by Type (2016-2026)
8.2 Europe Alimta Sales by Application (2016-2026)
8.3 Europe Alimta Market Size by Country
8.3.1 Europe Alimta Sales in Volume by Country (2016-2026)
8.3.2 Europe Alimta Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Alimta Sales by Type (2016-2026)
9.2 Asia-Pacific Alimta Sales by Application (2016-2026)
9.3 Asia-Pacific Alimta Market Size by Region
9.3.1 Asia-Pacific Alimta Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Alimta Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Alimta Sales by Type (2016-2026)
10.2 South America Alimta Sales by Application (2016-2026)
10.3 South America Alimta Market Size by Country
10.3.1 South America Alimta Sales in Volume by Country (2016-2026)
10.3.2 South America Alimta Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Alimta Sales by Type (2016-2026)
11.2 Middle East & Africa Alimta Sales by Application (2016-2026)
11.3 Middle East & Africa Alimta Market Size by Country
11.3.1 Middle East & Africa Alimta Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Alimta Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Alimta Typical Distributors
12.3 Alimta Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Alimta Revenue by Type, (USD Million), 2021-2026
Table 2. Global Alimta Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Alimta Product and Services
Table 6. Eli Lilly Alimta Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Healthcare Major Business
Table 9. Abbott Healthcare Alimta Product and Services
Table 10. Abbott Healthcare Alimta Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. Cadila Healthcare Major Business
Table 13. Cadila Healthcare Alimta Product and Services
Table 14. Cadila Healthcare Alimta Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Eagle Pharmaceuticals Major Business
Table 17. Eagle Pharmaceuticals Alimta Product and Services
Table 18. Eagle Pharmaceuticals Alimta Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Alimta Sales by Manufacturer (2019-2021e) & (Kg)
Table 20. Global Alimta Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Alimta, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Alimta Production Capacity by Company, (Kg): 2020 VS 2021
Table 23. Head Office and Alimta Production Site of Key Manufacturer
Table 24. Alimta New Entrant and Capacity Expansion Plans
Table 25. Alimta Mergers & Acquisitions in the Past Five Years
Table 26. Global Alimta Sales by Region (2016-2021e) & (Kg)
Table 27. Global Alimta Sales by Region (2021-2026) & (Kg)
Table 28. Global Alimta Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Alimta Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Alimta Sales by Type (2016-2021e) & (Kg)
Table 31. Global Alimta Sales by Type (2021-2026) & (Kg)
Table 32. Global Alimta Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Alimta Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Alimta Price by Type (2016-2021e) & (USD/g)
Table 35. Global Alimta Price by Type (2021-2026) & (USD/g)
Table 36. Global Alimta Sales by Application (2016-2021e) & (Kg)
Table 37. Global Alimta Sales by Application (2021-2026) & (Kg)
Table 38. Global Alimta Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Alimta Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Alimta Price by Application (2016-2021e) & (USD/g)
Table 41. Global Alimta Price by Application (2021-2026) & (USD/g)
Table 42. North America Alimta Sales by Country (2016-2021e) & (Kg)
Table 43. North America Alimta Sales by Country (2021-2026) & (Kg)
Table 44. North America Alimta Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Alimta Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Alimta Sales by Type (2016-2021e) & (Kg)
Table 47. North America Alimta Sales by Type (2021-2026) & (Kg)
Table 48. North America Alimta Sales by Application (2016-2021e) & (Kg)
Table 49. North America Alimta Sales by Application (2021-2026) & (Kg)
Table 50. Europe Alimta Sales by Country (2016-2021e) & (Kg)
Table 51. Europe Alimta Sales by Country (2021-2026) & (Kg)
Table 52. Europe Alimta Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Alimta Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Alimta Sales by Type (2016-2021e) & (Kg)
Table 55. Europe Alimta Sales by Type (2021-2026) & (Kg)
Table 56. Europe Alimta Sales by Application (2016-2021e) & (Kg)
Table 57. Europe Alimta Sales by Application (2021-2026) & (Kg)
Table 58. Asia-Pacific Alimta Sales by Region (2016-2021e) & (Kg)
Table 59. Asia-Pacific Alimta Sales by Region (2021-2026) & (Kg)
Table 60. Asia-Pacific Alimta Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Alimta Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Alimta Sales by Type (2016-2021e) & (Kg)
Table 63. Asia-Pacific Alimta Sales by Type (2021-2026) & (Kg)
Table 64. Asia-Pacific Alimta Sales by Application (2016-2021e) & (Kg)
Table 65. Asia-Pacific Alimta Sales by Application (2021-2026) & (Kg)
Table 66. South America Alimta Sales by Country (2016-2021e) & (Kg)
Table 67. South America Alimta Sales by Country (2021-2026) & (Kg)
Table 68. South America Alimta Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Alimta Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Alimta Sales by Type (2016-2021e) & (Kg)
Table 71. South America Alimta Sales by Type (2021-2026) & (Kg)
Table 72. South America Alimta Sales by Application (2016-2021e) & (Kg)
Table 73. South America Alimta Sales by Application (2021-2026) & (Kg)
Table 74. Middle East & Africa Alimta Sales by Country (2016-2021e) & (Kg)
Table 75. Middle East & Africa Alimta Sales by Country (2021-2026) & (Kg)
Table 76. Middle East & Africa Alimta Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Alimta Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Alimta Sales by Type (2016-2021e) & (Kg)
Table 79. Middle East & Africa Alimta Sales by Type (2021-2026) & (Kg)
Table 80. Middle East & Africa Alimta Sales by Application (2016-2021e) & (Kg)
Table 81. Middle East & Africa Alimta Sales by Application (2021-2026) & (Kg)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Alimta Typical Distributors
Table 85. Alimta Typical Customers
List of Figures
Figure 1. Alimta Picture
Figure 2. Global Alimta Sales Market Share by Type in 2020
Figure 3. 100mg
Figure 4. 500mg
Figure 5. Global Alimta Sales Market Share by Application in 2020
Figure 6. Pleural Mesothelioma
Figure 7. Non-small Cell Lung Cancer
Figure 8. Global Alimta Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 9. Global Alimta Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Alimta Sales (2016-2026) & (Kg)
Figure 11. Global Alimta Price by Type (2016-2026) & (USD/g)
Figure 12. Global Alimta Production Capacity (2016-2026) & (Kg)
Figure 13. Global Alimta Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Alimta Market Drivers
Figure 15. Alimta Market Restraints
Figure 16. Alimta Market Trends
Figure 17. Global Alimta Sales Market Share by Manufacturer in 2020
Figure 18. Global Alimta Revenue Market Share by Manufacturer in 2020
Figure 19. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Alimta Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Alimta Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Alimta Sales Market Share by Region (2016-2026)
Figure 23. Global Alimta Revenue Market Share by Region (2016-2026)
Figure 24. North America Alimta Revenue (2016-2026) & (USD Million)
Figure 25. Europe Alimta Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Alimta Revenue (2016-2026) & (USD Million)
Figure 27. South America Alimta Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Alimta Revenue (2016-2026) & (USD Million)
Figure 29. Global Alimta Sales Market Share by Type (2016-2026)
Figure 30. Global Alimta Revenue Market Share by Type (2016-2026)
Figure 31. Global Alimta Price by Type (2016-2026) & (USD/g)
Figure 32. Global Alimta Sales Market Share by Application (2016-2026)
Figure 33. Global Alimta Revenue Market Share by Application (2016-2026)
Figure 34. Global Alimta Price by Application (2016-2026) & (USD/g)
Figure 35. North America Alimta Sales Market Share by Type (2016-2026)
Figure 36. North America Alimta Sales Market Share by Application (2016-2026)
Figure 37. North America Alimta Sales Market Share by Country (2016-2026)
Figure 38. North America Alimta Revenue Market Share by Country (2016-2026)
Figure 39. United States Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Alimta Sales Market Share by Type (2016-2026)
Figure 43. Europe Alimta Sales Market Share by Application (2016-2026)
Figure 44. Europe Alimta Sales Market Share by Country (2016-2026)
Figure 45. Europe Alimta Revenue Market Share by Country (2016-2026)
Figure 46. Germany Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Alimta Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Alimta Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Alimta Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Alimta Revenue Market Share by Region (2016-2026)
Figure 55. China Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Alimta Sales Market Share by Type (2016-2026)
Figure 62. South America Alimta Sales Market Share by Application (2016-2026)
Figure 63. South America Alimta Sales Market Share by Country (2016-2026)
Figure 64. South America Alimta Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Alimta Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Alimta Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Alimta Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Alimta Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Alimta Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
小細胞肺がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…- 世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- がん幹細胞の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through gen…
- 腫瘍学バイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment. Biosimilars are cost-effective molecules with the same efficacy and potency as the original reference biologic. The relatively easy man…
- スモールセルネットワークの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Small cells are low-powered cellular radio access nodes that operate in licensed and unlicensed spectrum that have a range of 10 meters to a few kilometers. They are "small" compared to a mobile macrocell, partly because they have a shorter range and partly because they typically handle fewer concur…